Jan 10, 2022Results of First US Clinical Trial of Alpha DaRTâ„¢Alpha Tau Announces Results of First US Clinical Trial of Alpha DaRTâ„¢ in Malignant Skin & Soft Tissue Cancers, Showing Complete Response...
Jan 3, 2022Completion of Enrollment of Japanese Pivotal Clinical Trial in Recurrent Head & Neck CancerJERUSALEM, Dec. 31, 2021 -- Alpha Tau Medical Ltd. ("Alpha Tau"), the developer of the innovative alpha-radiation cancer therapy Alpha...
Jan 2, 2022Alpha DaRT Investigator Meeting in Las VegasComing Up Soon - Alpha DaRT Investigator Meeting in Las Vegas Alpha Tau is pleased to announce that the Alpha DaRT Investigator Meeting,...
Nov 4, 2021Enrollment of First Patient in Combination Trial of Alpha DaRT™ and Pembrolizumab (Keytruda®)JERUSALEM, Nov. 3, 2021 -- Alpha Tau Medical Ltd. ("Alpha Tau"), the developer of the innovative alpha-radiation cancer therapy Alpha...
Oct 26, 2021Completion of Enrollment in 1st US Clinical Trial & Achievement of 1st Primary ObjectiveJERUSALEM, Oct. 25, 2021 -- Alpha Tau Medical Ltd. ("Alpha Tau"), the developer of the innovative alpha-radiation cancer therapy Alpha...